SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.431
EU - Europa 4.664
AS - Asia 2.616
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
AF - Africa 1
Totale 20.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.409
CN - Cina 1.694
IT - Italia 1.194
UA - Ucraina 987
DE - Germania 858
TR - Turchia 747
GB - Regno Unito 448
SE - Svezia 311
FR - Francia 295
FI - Finlandia 239
PL - Polonia 142
VN - Vietnam 108
RU - Federazione Russa 84
BE - Belgio 55
IN - India 24
HK - Hong Kong 12
CA - Canada 10
IE - Irlanda 10
IR - Iran 10
BR - Brasile 8
ES - Italia 8
EU - Europa 8
JP - Giappone 7
AU - Australia 6
NL - Olanda 6
SV - El Salvador 6
AT - Austria 5
RO - Romania 5
KR - Corea 4
MX - Messico 4
CH - Svizzera 3
EC - Ecuador 3
NZ - Nuova Zelanda 3
SG - Singapore 3
CO - Colombia 2
IL - Israele 2
PT - Portogallo 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 20.744
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.778
Fairfield 1.671
Houston 1.184
Jacksonville 1.118
Chandler 1.097
Ashburn 822
Ann Arbor 790
Seattle 660
Wilmington 642
Cambridge 561
Beijing 468
Izmir 436
Nanjing 368
Princeton 288
Ferrara 260
New York 196
San Diego 157
Milan 150
Boardman 137
Warsaw 132
Shanghai 124
Nanchang 116
Shenyang 112
Dong Ket 108
Bremen 100
Addison 99
Hebei 70
Jiaxing 67
Tianjin 63
Dearborn 62
Changsha 60
Brussels 55
Falls Church 44
Rome 44
Jinan 42
Norwalk 41
Redwood City 36
Mountain View 34
San Mateo 34
Zhengzhou 31
London 28
Los Angeles 23
Augusta 22
Kunming 22
Ningbo 22
Verona 21
Auburn Hills 19
Washington 19
Haikou 18
Bari 17
Bologna 17
Des Moines 17
Guangzhou 17
Hefei 14
Lappeenranta 14
Naples 14
Orange 14
San Jose 14
Hangzhou 13
Leawood 13
Taizhou 13
Tappahannock 13
Lanzhou 11
Lozzo Atestino 11
Monmouth Junction 11
Changchun 10
Helsinki 10
Hong Kong 10
Indiana 10
Redmond 10
Napoli 9
Philadelphia 9
Florence 8
Voghera 8
Dublin 7
Mumbai 7
Trieste 7
Ardabil 6
Chicago 6
Chiswick 6
Fuzhou 6
Hounslow 6
Modena 6
Palermo 6
Reggio Nell'emilia 6
San Salvador 6
Avellino 5
Mareno Di Piave 5
Melito di Napoli 5
San Francisco 5
Vienna 5
Brescia 4
Chengdu 4
Delhi 4
Messina 4
Perugia 4
Pisa 4
Radomsko 4
Saronno 4
Tucson 4
Totale 14.894
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 576
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 175
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 164
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 159
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 152
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 152
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 152
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 148
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 146
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 142
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 142
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 140
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 133
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 131
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 131
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 130
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 128
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 127
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 125
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 125
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 125
Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma 125
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 124
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 124
null 124
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 122
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 120
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 119
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 118
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 117
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 117
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 117
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 116
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 116
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings, 116
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 115
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 115
Exercise training and endothelial progenitor cells in haemodialysis patients 115
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 115
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 113
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 112
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 112
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 112
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 111
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 111
Hepatosplenic T-cell lymphoma (HSTCL). 110
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 110
Delirium in acute promyelocytic leukemia patients: two case reports. 110
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 108
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 108
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 108
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 107
Dendritic cells in acute promyelocytic leukaemia 106
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 106
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 106
null 106
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 106
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 105
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 105
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 105
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 105
Cytogenetics in myelodysplastic syndromes: Old methods, new clues 104
The role of rHuEpo in low-risk myelodysplastic syndrome patients 103
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 102
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 101
Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia. 101
Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan 100
null 100
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 100
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 100
CD34+CD33+ blast cells: Correlation with FAB subtypes 99
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 99
Intestinal T-cell lymphoma 98
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial 98
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 97
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 97
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 97
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 97
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. 96
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 96
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 96
CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY 96
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 94
The monocytic component in myelodysplastic syndromes. 94
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 94
null 94
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 93
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 92
null 92
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 92
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 92
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 91
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 90
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 90
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 90
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 90
Reproducible Diagnosis of Chronic Lymphocytic Leukemia (CLL) By Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project 89
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review 89
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 88
Totale 11.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.767
Totale 90.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.522 0 0 0 0 0 0 0 0 0 0 469 1.053
2019/20204.457 815 126 134 624 286 510 376 439 339 477 238 93
2020/20213.589 237 265 208 343 141 328 155 374 87 518 575 358
2021/20222.856 207 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.026 138 155 76 50 99 244 74 98 38 50 4 0
Totale 21.169